DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain
Open Access
- 13 August 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-12
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of several anti-neoplastics and a main cause of sensory disturbances in cancer survivors, negatively impacting patients’ quality of life. Peripheral nerve degeneration or small fibre neuropathy is generally accepted as the underlying mechanism in the development of CIPN. Recent evidence has contributed to clarify the determinant role of cytokines and chemokines in the process leading to neuronal hyperexcitability. Exposure to oxaliplatin triggers alterations in peripheral neuropathic pathways previously linked to IL-8 pathway. We investigated a novel selective inhibitor of IL-8 receptors, DF2726A, and showed its effects in counteracting CINP pathways, extending the relevance of the activation of IL-8 pathway to the class of platinum chemotherapeutics. Based on our results, we suggest that DF2726A might be a promising candidate for clinical treatment of CIPN conditions due to its efficacy and optimized pharmacokinetic/pharmacodynamic profile.Keywords
This publication has 35 references indexed in Scilit:
- Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathyCytokine, 2012
- Targeting pain mediators induced by injured nerve-derived COX2 and PGE2 to treat neuropathic painExpert Opinion on Therapeutic Targets, 2012
- Longitudinal assessment of oxaliplatin-induced neuropathyNeurology, 2011
- Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocyclineExperimental Neurology, 2011
- Terminal arbor degeneration - a novel lesion produced by the antineoplastic agent paclitaxelEuropean Journal of Neuroscience, 2011
- Intraepidermal nerve fiber loss corresponds to the development of Taxol-induced hyperalgesia and can be prevented by treatment with minocyclinePain, 2011
- NGF protects Dorsal Root Ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2Neuroscience Letters, 2010
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategiesEuropean Journal of Cancer, 2008
- Chemotherapy-associated neurotoxicity: an important side effect-impacting on quality, rather than quantity, of lifeJournal of Cancer Research and Clinical Oncology, 1996